BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 11483851)

  • 1. Cystic fibrosis.
    Davis PB
    Pediatr Rev; 2001 Aug; 22(8):257-64. PubMed ID: 11483851
    [No Abstract]   [Full Text] [Related]  

  • 2. Sweat Chloride Testing.
    McCarthy C; Clancy JP; Brewington J
    JAMA; 2019 Feb; 321(7):701-702. PubMed ID: 30698611
    [No Abstract]   [Full Text] [Related]  

  • 3. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis.
    Keating CL; Liu X; Dimango EA
    Chest; 2010 May; 137(5):1157-63. PubMed ID: 19965956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is early identification of asymptomatic infants with 'mild' CFTR genotypes clinically useful?
    Colombo C; Costantini D; Russo MC; Claut L; Porcaro L; Nobili R
    Acta Paediatr; 2007 Mar; 96(3):477-9. PubMed ID: 17407489
    [No Abstract]   [Full Text] [Related]  

  • 5. Misdiagnosis of cystic fibrosis based on transient pancreatic insufficiency and elevated sweat chloride.
    Bagheri-Behrouzi A; Steiß JO; Zimmer KP; Nährlich L
    Klin Padiatr; 2015 Mar; 227(2):96-7. PubMed ID: 25751685
    [No Abstract]   [Full Text] [Related]  

  • 6. Sweat chloride testing: controversies and issues.
    Kharrazi M; Milla C; Wine J
    Lancet Respir Med; 2016 Aug; 4(8):605-607. PubMed ID: 27511631
    [No Abstract]   [Full Text] [Related]  

  • 7. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator 11234V mutation.
    Al-Mendalawi MD; Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2010 Mar; 31(3):339-40; author reply 340. PubMed ID: 20231949
    [No Abstract]   [Full Text] [Related]  

  • 8. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations.
    Highsmith WE; Burch LH; Zhou Z; Olsen JC; Boat TE; Spock A; Gorvoy JD; Quittel L; Friedman KJ; Silverman LM
    N Engl J Med; 1994 Oct; 331(15):974-80. PubMed ID: 7521937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: importance of follow-up that includes monitoring sweat chloride concentrations over time.
    Williams SN; Nussbaum E; Chin TW; Do PC; Singh KE; Randhawa I
    Pediatr Pulmonol; 2014 Mar; 49(3):E103-8. PubMed ID: 24535988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications and management of cystic fibrosis screen positive, inconclusive diagnosis patients.
    Krishnananthan T; Pao C
    Paediatr Respir Rev; 2019 Aug; 31():21-24. PubMed ID: 31153793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When to suspect atypical cystic fibrosis.
    Chawla A; Turcotte FG; Usmani K; Kanu AC
    J Fam Pract; 2010 Sep; 59(9):509-13. PubMed ID: 20824227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis mutations in heterozygous newborns with hypertrypsinemia and low sweat chloride.
    Castellani C; Benetazzo MG; Bonizzato A; Pignatti PF; Mastella G
    Am J Hum Genet; 1999 Jan; 64(1):303-4. PubMed ID: 9915972
    [No Abstract]   [Full Text] [Related]  

  • 14. CF or not CF? That is the question.
    Dodge JA; Dequeker E
    J Cyst Fibros; 2002 Mar; 1(1):3-4. PubMed ID: 15463804
    [No Abstract]   [Full Text] [Related]  

  • 15. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection.
    Ziedalski TM; Kao PN; Henig NR; Jacobs SS; Ruoss SJ
    Chest; 2006 Oct; 130(4):995-1002. PubMed ID: 17035430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Devil in the detail of newborn screening for cystic fibrosis.
    Doull I
    Arch Dis Child; 2019 Oct; 104(10):938-940. PubMed ID: 30389674
    [No Abstract]   [Full Text] [Related]  

  • 17. Sweat chloride concentration in cystic fibrosis patients with cystic fibrosis trans-membrane conductance regulator I1234V mutation.
    Abdul-Wahab A; Janahi IA; Abdel-Rahman MO
    Saudi Med J; 2009 Aug; 30(8):1101-2. PubMed ID: 19668897
    [No Abstract]   [Full Text] [Related]  

  • 18. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis.
    Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR
    Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of the cystic fibrosis gene and pancreatitis.
    Ren CL
    N Engl J Med; 1999 Jan; 340(3):238-9. PubMed ID: 9917235
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thoracic findings in pediatric patients with cystic fibrosis].
    Wunsch R; Wunsch C
    Radiologe; 2003 Dec; 43(12):1103-8. PubMed ID: 14668999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.